We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Phage Therapy Trial Launched Following FDA Approval

News   Feb 25, 2019 | Original Story by Scott LaFee and Heather Buschman for the University of California San Diego Health.

 
Phage Therapy Trial Launched Following FDA Approval

Colorized micrograph of bacteriophages (green) attacking a bacterium. Credit: Thomas Deerinck, National Center for Microscopy and Imaging Research, UC San Diego.

 
 
 

RELATED ARTICLES

Vital Iron Sensing in Nitrogen-fixing Bacteria

News

Researchers have discovered how nitrogen-fixing bacteria sense iron - an essential but deadly micronutrient.

READ MORE

Mutating Ebola Virus Protein Works as a Vaccine to Protect Animals From Infection

News

Creating mutations in a key Ebola virus protein that helps the deadly virus escape from the body's defenses can make the virus unable to produce sickness and activate protective immunity in the infected host, according to a study by the Institute for Biomedical Sciences at Georgia State University.

READ MORE

Model Shows How Algal Toxin May Cause ALS

News

A computer generated-simulation has allowed researchers to see how a toxin produced by algal blooms in saltwater might cause Amyotrophic Lateral Sclerosis (ALS).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE